Intuitive Surgical Q4 2025 revenue rose 19% y/y; 2026 procedure guidance disappointed, but da Vinci 5 strength supports Buy—read now.

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the stocks on Jim Cramer’s game plan for this week. Cramer was bullish on ...

Over 3 million procedures were performed globally on Intuitive daVinci systems last year, accounting for an 18% increase.

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving ...

Intuitive Surgical released specifics on its Ion platform, reporting 51% YoY growth in Ion procedures for 2025.

In recent days, Intuitive Surgical reported strong demand for its da Vinci robotic systems, with procedure volumes rising ...

Shares of Intuitive Surgical (NASDAQ: ISRG) were pulling back today as a strong fourth-quarter earnings report didn't seem to be enough to justify the medical device maker's lofty valuation. Its ...

Despite the revenue beat, investors appeared concerned about a slowdown in Ion endoluminal system placements, which fell to 42 in the fourth quarter compared to 69 in the same period last year. The ...

Intuitive Surgical, Inc. stock: da Vinci robotics leader with 80% share, recurring revenue, fast procedure growth and solid ...

ISRG posts strong preliminary Q4 and full-year 2025 revenue growth, but shares dip as investors weigh procedure trends, ...